2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment
Molecules · 2024
DOI: 10.3390/molecules29143375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Miglena Milusheva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Phenethylamines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder characterized by abdominal pain or discomfort. Mebeverine is an antispasmodic that has been widely used in clinical practice to relieve the symptoms of IBS. However, its systemic use usually leads to side effects. Therefore, the current paper aimed to synthesize more effective medicines for IBS treatment. We used ring opening of isatoic anhydride for the synthesis in reaction with 2-phenylethylamine. In silico simulation predicted spasmolytic activity for 2-amino-N-phenethylbenzamides. The newly synthesized compounds demonstrated a relaxation effect similar to mebeverine but did not affect the serotonin or Ca2+-dependent signaling pathway of contractile activity (CA) in contrast. Having in mind the anti-inflammatory potential of antispasmodics, the synthesized molecules were tested in vitro and ex vivo for their anti-inflammatory effects. Four of the newly synthesized compounds demonstrated very good activity by preventing albumin denaturation compared to anti-inflammatory drugs/agents well-established in medicinal practice. The newly synthesized compounds also inhibited the expression of interleukin-1β and stimulated the expression of neuronal nitric oxide synthase (nNOS), and, consequently, nitric oxide (NO) synthesis by neurons of the myenteric plexus. This characterizes the newly synthesized compounds as biologically active relaxants, offering a cleaner and more precise application in pharmacological practice, thereby enhancing their potential therapeutic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Bioorganic Chemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Department of General and Inorganic Chemistry with Methodology of Chemistry Education, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Analytical Chemistry and Computer Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
ORCID-Profile: Miglena Milusheva, Mihaela Stoyanova, Vera Gledacheva, Iliyana Stefanova, Mina Todorova, Mina Pencheva, Kirila Stojnova, Slava Tsoneva, Paraskev Nedialkov, Stoyanka Nikolova
Förderung
- European Union-NextGenerationEU
Zitieren
APA
Milusheva, M., Stoyanova, M., Gledacheva, V., Stefanova, I., Todorova, M., Pencheva, M., Stojnova, K., Tsoneva, S., Nedialkov, P., & Nikolova, S. (2024). 2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment. Molecules. https://doi.org/10.3390/molecules29143375
Vancouver
Milusheva M, Stoyanova M, Gledacheva V, Stefanova I, Todorova M, Pencheva M, et al. 2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment. Molecules. 2024. doi:10.3390/molecules29143375
BibTeX
@article{Milusheva2024,
author = {Milusheva, Miglena and Stoyanova, Mihaela and Gledacheva, Vera and Stefanova, Iliyana and Todorova, Mina and Pencheva, Mina and Stojnova, Kirila and Tsoneva, Slava and Nedialkov, Paraskev and Nikolova, Stoyanka},
title = {2-Amino-N-Phenethylbenzamides for Irritable Bowel Syndrome Treatment},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29143375}
}
EUVIMED